Optimising T cell (re)boosting strategies for adenoviral and modified vaccinia Ankara vaccine regimens in humans
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Optimising T cell (re)boosting strategies for adenoviral and modified vaccinia Ankara vaccine regimens in humans
Authors
Keywords
-
Journal
npj Vaccines
Volume 5, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-10-12
DOI
10.1038/s41541-020-00240-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial
- (2020) Pedro M Folegatti et al. LANCET INFECTIOUS DISEASES
- A Novel Vaccine Strategy Employing Serologically Different Chimpanzee Adenoviral Vectors for the Prevention of HIV-1 and HCV Coinfection
- (2019) Felicity Hartnell et al. Frontiers in Immunology
- Rational Zika vaccine design via the modulation of antigen membrane anchors in chimpanzee adenoviral vectors
- (2018) César López-Camacho et al. Nature Communications
- Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAP
- (2018) Carly M. Bliss et al. Scientific Reports
- Induction and Maintenance of CX3CR1-Intermediate Peripheral Memory CD8 + T Cells by Persistent Viruses and Vaccines
- (2018) Claire Louse Gordon et al. Cell Reports
- Heterologous Two-Dose Vaccination with Simian Adenovirus and Poxvirus Vectors Elicits Long-Lasting Cellular Immunity to Influenza Virus A in Healthy Adults
- (2018) L. Coughlan et al. EBioMedicine
- Replication deficient human adenovirus vector serotype 19a/64: Immunogenicity in mice and female cynomolgus macaques
- (2018) Emeline Ragonnaud et al. VACCINE
- Safety and efficacy of novel malaria vaccine regimens of RTS,S/AS01B alone, or with concomitant ChAd63-MVA-vectored vaccines expressing ME-TRAP
- (2018) Tommy Rampling et al. npj Vaccines
- Chimpanzee adenoviral vectors as vaccines – challenges to move the technology into the fast lane
- (2017) Alessandra Vitelli et al. Expert Review of Vaccines
- Is a Human CD8 T-Cell Vaccine Possible, and if So, What Would It Take?
- (2017) Andrew J. McMichael Cold Spring Harbor Perspectives in Biology
- Is a Human CD8 T-Cell Vaccine Possible, and if So, What Would It Take?
- (2017) Lalit K. Beura et al. Cold Spring Harbor Perspectives in Biology
- Ad26/MVA therapeutic vaccination with TLR7 stimulation in SIV-infected rhesus monkeys
- (2016) Erica N. Borducchi et al. NATURE
- A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA
- (2016) Katie Ewer et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Phase I Randomized Therapeutic MVA-B Vaccination Improves the Magnitude and Quality of the T Cell Immune Responses in HIV-1-Infected Subjects on HAART
- (2015) Carmen Elena Gómez et al. PLoS One
- Chimpanzee adenovirus– and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults
- (2015) Christopher A. Green et al. Science Translational Medicine
- Efficacy of a virus-vectored vaccine against human and bovine respiratory syncytial virus infections
- (2015) Geraldine Taylor et al. Science Translational Medicine
- Adenoviral Vector Vaccination Induces a Conserved Program of CD8+ T Cell Memory Differentiation in Mouse and Man
- (2015) Beatrice Bolinger et al. Cell Reports
- Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial
- (2015) Birahim Pierre Ndiaye et al. Lancet Respiratory Medicine
- Safety and Immunogenicity of Modified Vaccinia Ankara-Bavarian Nordic Smallpox Vaccine in Vaccinia-Naive and Experienced Human Immunodeficiency Virus-Infected Individuals: An Open-Label, Controlled Clinical Phase II Trial
- (2015) E. T. Overton et al. Open Forum Infectious Diseases
- Are effector memory T cells the key to an effective HIV/AIDS vaccine?
- (2014) L. J. Picker EMBO REPORTS
- Safety and immunogenicity of a modified-vaccinia-virus-Ankara-based influenza A H5N1 vaccine: a randomised, double-blind phase 1/2a clinical trial
- (2014) Joost H C M Kreijtz et al. LANCET INFECTIOUS DISEASES
- Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge
- (2014) Daphne A Stanley et al. NATURE MEDICINE
- A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory
- (2014) L. Swadling et al. Science Translational Medicine
- Coadministration of Seasonal Influenza Vaccine and MVA-NP+M1 Simultaneously Achieves Potent Humoral and Cell-Mediated Responses
- (2013) Richard D Antrobus et al. MOLECULAR THERAPY
- Cellular immune correlates of protection against symptomatic pandemic influenza
- (2013) Saranya Sridhar et al. NATURE MEDICINE
- Safety and Immunogenicity of Heterologous Prime-Boost Immunisation with Plasmodium falciparum Malaria Candidate Vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in Healthy Gambian and Kenyan Adults
- (2013) Caroline Ogwang et al. PLoS One
- Recombinant MVA vaccines: dispelling the myths
- (2013) Matthew G. Cottingham et al. VACCINE
- Endogenous antigen presentation impacts on T-box transcription factor expression and functional maturation of CD8+ T cells
- (2012) C. Smith et al. BLOOD
- Chronic HIV infection affects the expression of the 2 transcription factors required for CD8 T-cell differentiation into cytolytic effectors
- (2012) P. Ribeiro-dos-Santos et al. BLOOD
- Network Analysis Reveals Centrally Connected Genes and Pathways Involved in CD8+ T Cell Exhaustion versus Memory
- (2012) Travis A. Doering et al. IMMUNITY
- Clinical Assessment of a Recombinant Simian Adenovirus ChAd63: A Potent New Vaccine Vector
- (2012) Geraldine A. O’Hara et al. JOURNAL OF INFECTIOUS DISEASES
- ChAd63-MVA–vectored Blood-stage Malaria Vaccines Targeting MSP1 and AMA1: Assessment of Efficacy Against Mosquito Bite Challenge in Humans
- (2012) Susanne H Sheehy et al. MOLECULAR THERAPY
- Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys
- (2012) Dan H. Barouch et al. NATURE
- Pre-Existing Vector Immunity Does Not Prevent Replication Deficient Adenovirus from Inducing Efficient CD8 T-Cell Memory and Recall Responses
- (2012) Maria Abildgaard Steffensen et al. PLoS One
- Merck Ad5/HIV induces broad innate immune activation that predicts CD8+ T-cell responses but is attenuated by preexisting Ad5 immunity
- (2012) D. E. Zak et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Progenitor and Terminal Subsets of CD8+ T Cells Cooperate to Contain Chronic Viral Infection
- (2012) M. A. Paley et al. SCIENCE
- Vaccine Vectors Derived from a Large Collection of Simian Adenoviruses Induce Potent Cellular Immunity Across Multiple Species
- (2012) S. Colloca et al. Science Translational Medicine
- Novel Adenovirus-Based Vaccines Induce Broad and Sustained T Cell Responses to HCV in Man
- (2012) E. Barnes et al. Science Translational Medicine
- Phase Ia Clinical Evaluation of the Plasmodium falciparum Blood-stage Antigen MSP1 in ChAd63 and MVA Vaccine Vectors
- (2011) Susanne H Sheehy et al. MOLECULAR THERAPY
- Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine
- (2011) Scott G. Hansen et al. NATURE
- Transcription factor T-bet represses expression of the inhibitory receptor PD-1 and sustains virus-specific CD8+ T cell responses during chronic infection
- (2011) Charlly Kao et al. NATURE IMMUNOLOGY
- A human Phase I/IIa malaria challenge trial of a polyprotein malaria vaccine
- (2011) David W. Porter et al. VACCINE
- The mTOR Kinase Determines Effector versus Memory CD8 + T Cell Fate by Regulating the Expression of Transcription Factors T-bet and Eomesodermin
- (2010) Rajesh R. Rao et al. IMMUNITY
- Living in a house of cards: re-evaluating CD8+ T-cell immune correlates against HIV
- (2010) George Makedonas et al. IMMUNOLOGICAL REVIEWS
- Adenovirus-specific human T cells are pervasive, polyfunctional, and cross-reactive
- (2010) Natalie A. Hutnick et al. VACCINE
- The relationship between human effector and memory T cells measured byex vivoand cultured ELISPOT following recent and distal priming
- (2009) Stephen M. Todryk et al. IMMUNOLOGY
- Runx3 and T-box proteins cooperate to establish the transcriptional program of effector CTLs
- (2009) Fernando Cruz-Guilloty et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Erratum: Corrigendum: Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge.
- (2009) Scott G Hansen et al. NATURE MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search